MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
48.00
-1.02 (-2.08%)
Oct 22, 2024, 4:00 PM EDT - Market closed

MLTX Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for MLTX stock have an average target of 78, with a low estimate of 62 and a high estimate of 104. The average target predicts an increase of 62.50% from the current stock price of 48.00.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $62 $78 $72 $104
Change +29.17% +62.50% +50.00% +116.67%

Analyst Ratings

The average analyst rating for MLTX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 555555
Buy 333222
Hold 222322
Sell 000000
Strong Sell 000000
Total 1010101099

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +108.33% Oct 15, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Sep 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +108.33% Sep 12, 2024
Needham
Needham
Strong Buy
Reiterates
$62
Strong Buy Reiterates $62 +29.17% Sep 12, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Sep 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.59
from -0.73
EPS Next Year
-2.42
from -1.59
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
------136.11M585.10M
Revenue Growth
-------329.87%
EPS
-8.21-1.70-0.73-1.59-2.42-3.31-2.100.89
EPS Growth
--------
Forward PE
-------53.68
No. Analysts ---18161355
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20242025202620272028
High -1.40 -1.18 -2.88
Avg -1.59 -2.42 -3.31
Low -1.76 -2.74 -3.70

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.